EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction of a UBE2S‐ and Ferroptosis‐Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S‐Mediated Ferroptosis

Hao Zhang, Jiajun Yao, Jun Cao, Zehao Guo, Wendong Jiang, Kangzhi Li, Xiaoyan Wang, Zhijing Mo iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/2592640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 08.11.2026. Verfasst von Hao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cell and Gene Therapy for Regional High-incidence Diseases Education Department of Guangxi Zhuang Autonomous Region Guilin Medical …. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Ubiquitin-Conjugating Enzymes. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study is aimed at exploring whether ubiquitin‐conjugating enzyme E2 S (UBE2S) influences hepatocellular carcinoma (HCC) progression through ferroptosis and at constructing a UBE2S‐related ferroptosis prognostic model (UFP) for predicting clinical outcomes in HCC patients.

Methods

Bioinformatics approaches were employed to examine how UBE2S expression relates to both HCC prognosis and ferroptosis. Tumor immune infiltration was assessed using CIBERSORT with the LM22 signature matrix. The prognostic accuracy of the UFP, which integrates CENPA and PAGE1, was assessed via survival analysis, ROC curves, and calibration plots. For experimental validation, ferroptosis‐related markers were measured following UBE2S overexpression or knockdown, or after treatment with the ferroptosis inducers erastin and sorafenib. Additionally, tumor weight, size, and ferroptosis‐associated proteins were examined in a xenograft model following combined UBE2S knockdown and sorafenib treatment.

Results

In HCC, elevated UBE2S expression predicted poor prognosis, suppressed ferroptosis, and correlated with an immunosuppressive microenvironment. The UFP model demonstrated robust prognostic performance, as validated using ICGC and single‐cell datasets. UBE2S knockdown promoted ferroptosis, as shown by increased Fe 2+ , MDA, and ROS levels and decreased GSH, whereas UBE2S overexpression reversed erastin‐induced ferroptosis. Moreover, UBE2S knockdown downregulated GPX4 and SLC7A11, whereas UBE2S overexpression upregulated these proteins. Sorafenib reduced UBE2S levels, and UBE2S overexpression reversed sorafenib‐induced ferroptosis. In xenograft models, UBE2S knockdown combined with sorafenib reduced tumor growth and enhanced ferroptosis.

Conclusion

The UFP model serves as a novel prognostic biomarker for HCC outcomes. Mechanistically, UBE2S suppression promotes ferroptosis and inhibits tumor progression, highlighting this protein as a promising therapeutic candidate. Collectively, our results offer fresh perspectives on HCC management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, HepatocellularLiver NeoplasmsUbiquitin-Conjugating EnzymesHumansPrognosisAnimalsMiceGene Expression Regulation, NeoplasticBiomarkers, TumorSorafenibComputational BiologyCell Line, TumorXenograft Model Antitumor AssaysFemale

Stichwörter der Autor:innen

ferroptosishepatocellular carcinomaprognosissorafenib

Substanzen

Ubiquitin-Conjugating EnzymesBiomarkers, TumorUbe2S protein, humanSorafenib

Autor:innen und Institutionen

  • Key Laboratory of Cell and Gene Therapy for Regional High-incidence Diseases Education Department of Guangxi Zhuang Autonomous Region Guilin Medical University Guilin China glmc.edu.cn.
  • Department of Biochemistry College of Basic Medical Sciences Guilin Medical University Guilin China glmc.edu.cn.

ORCID-Profile: Zhijing Mo

Förderung

  • Natural Science Foundation of Guangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, H., Yao, J., Cao, J., Guo, Z., Jiang, W., Li, K., Wang, X., & Mo, Z. (2026). Construction of a UBE2S‐ and Ferroptosis‐Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S‐Mediated Ferroptosis. Human Mutation, 2026(1). https://doi.org/10.1155/humu/2592640

Vancouver

Zhang H, Yao J, Cao J, Guo Z, Jiang W, Li K, et al. Construction of a UBE2S‐ and Ferroptosis‐Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S‐Mediated Ferroptosis. Human Mutation. 2026;2026(1). doi:10.1155/humu/2592640

BibTeX
@article{Zhang2026,
  author = {Zhang, Hao and Yao, Jiajun and Cao, Jun and Guo, Zehao and Jiang, Wendong and Li, Kangzhi and Wang, Xiaoyan and Mo, Zhijing},
  title = {Construction of a UBE2S‐ and Ferroptosis‐Based Prognostic Model for Hepatocellular Carcinoma and Validation of UBE2S‐Mediated Ferroptosis},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/2592640}
}
Kostenlos starten →